| Summary: | <p>Abstract</p> <p>Background</p> <p>Pulmonary vascular structure remodeling (PVSR) is a hallmark of pulmonary hypertension. P27<sup>kip1</sup>, one of critical cyclin-dependent kinase inhibitors, has been shown to mediate anti-proliferation effects on various vascular cells. Beta-estradiol (β-E2) has numerous biological protective effects including attenuation of hypoxic pulmonary hypertension (HPH). In the present study, we employed β-E2 to investigate the roles of p27<sup>kip1 </sup>and its closely-related kinase (Skp-2) in the progression of PVSR and HPH.</p> <p>Methods</p> <p>Sprague-Dawley rats treated with or without β-E2 were challenged by intermittent chronic hypoxia exposure for 4 weeks to establish hypoxic pulmonary hypertension models, which resemble moderate severity of hypoxia-induced PH in humans. Subsequently, hemodynamic and pulmonary pathomorphology data were gathered. Additionally, pulmonary artery smooth muscle cells (PASMCs) were cultured to determine the anti-proliferation effect of β-E2 under hypoxia exposure. Western blotting or reverse transcriptional polymerase chain reaction (RT-PCR) were adopted to test p27<sup>kip1</sup>, Skp-2 and Akt-P changes in rat lung tissue and cultured PASMCs.</p> <p>Results</p> <p>Chronic hypoxia significantly increased right ventricular systolic pressures (RVSP), weight of right ventricle/left ventricle plus septum (RV/LV+S) ratio, medial width of pulmonary arterioles, accompanied with decreased expression of p27<sup>kip1 </sup>in rats. Whereas, β-E2 treatment repressed the elevation of RVSP, RV/LV+S, attenuated the PVSR of pulmonary arterioles induced by chronic hypoxia, and stabilized the expression of p27<sup>kip1</sup>. Study also showed that β-E2 application suppressed the proliferation of PASMCs and elevated the expression of p27<sup>kip1 </sup>under hypoxia exposure. In addition, experiments both <it>in vivo </it>and <it>in vitro </it>consistently indicated an escalation of Skp-2 and phosphorylated Akt under hypoxia condition. Besides, all these changes were alleviated in the presence of β-E2.</p> <p>Conclusions</p> <p>Our results suggest that β-E2 can effectively attenuate PVSR and HPH. The underlying mechanism may partially be through the increased p27<sup>kip1 </sup>by inhibiting Skp-2 through Akt signal pathway. Therefore, targeting up-regulation of p27<sup>kip1 </sup>or down-regulation of Skp-2 might provide new strategies for treatment of HPH.</p>
|
|---|
